SCHEMBL8918703

SCHEMBL8918703

CCCCN(C(=O)NC)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
PTBP1 P26599 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
HSD11B1 P28845 1/20 0.39
ADH1A P07327 1/20 0.39
PYGL P06737 1/20 0.38
NAAA Q02083 1/20 0.38
UBE2M P61081 3/20 0.37
DCUN1D1 Q96GG9 3/20 0.37
EPHX1 P07099 5/20 0.37
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27574205 0.94 NAAA (0.43) ADH1ANAAAEPHX1THRATHRB
SCHEMBL8918667 0.90 ADH1A (0.44) LMNAL3MBTL1HSD11B1ADH1APYGL
SCHEMBL28004819 0.84 EPHX1 (0.49) ALDH1A1EPHX1EPHX2
SCHEMBL968899 0.82 L3MBTL1 (0.46) ALDH1A1LMNAL3MBTL1HSD11B1ADH1A
SCHEMBL19570761 0.81 L3MBTL1 (0.40) LMNAL3MBTL1HSD11B1ADH1APYGL
SCHEMBL5510945 0.81 L3MBTL1 (0.42) L3MBTL1HSD11B1ADH1APYGLNAAA
SCHEMBL628951 0.81 L3MBTL1 (0.42) ALDH1A1LMNAPTBP1L3MBTL1HSD11B1
SCHEMBL970246 0.80 L3MBTL1 (0.44) ALDH1A1LMNAL3MBTL1HSD11B1ADH1A
SCHEMBL9351634 0.80 EPHX1 (0.51) ALDH1A1EPHX1EPHX2
SCHEMBL18258653 0.80 NAAA (0.45) NAAAEPHX1THRATHRBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5591762-A HYPOTENSIVE AGENTS DR. KARL THOMAE GMBH (DE) 1997-01-07 US disclosed
US-5459147-A Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma DR. KARL THOMAE GMBH (DE) 1995-10-17 US disclosed